Background: Evidence from economic evaluations of hypertension treatment in high income countries has been reviewed in the literature. However, the needs of low and middle income countries are not met by these analyses as the cost effectiveness ratios appear inappropriate to the developing world context.
Objectives: To summarize and appraise evidence from published economic evaluations of hypertension treatment in low and middle income countries.
Methods: A computerized search for relevant studies was carried out on five main databases: Pubmed, Econlit, NHS EED, Cinahl and Embase. Quality of studies found was assessed using the Drummond checklist
Results: Seven studies have been included in the review, providing evidence of costeffectiveness of different treatment regimens as well as initial treatment approaches.
However, quality assessment has revealed a number of limitations in these studies regarding study perspective, validity, uncertainty and generalizability of the results.
Discussion and conclusion: Findings from the reviewed studies should be interpreted with . caution. It is suggested that number of improvements should be made in future economic evaluations in this area.